300 Rouse BoulevardPhiladelphia
Purpose-built for Iovance Biotherapeutics, this 137,000 sq ft, Class A facility was designed to meet the company's operational needs while allowing flexibility for future growth.
As a leading biopharmaceutical firm, Iovance manufactures its flagship product on site autologous, ready to infuse cell therapy that has shown notable effectiveness in treating metastatic melanoma.
The facility features aseptic manufacturing suites, analytical laboratories, dedicated spaces for training and process development, and general office areas.
As a leading biopharmaceutical firm, Iovance manufactures its flagship product on site autologous, ready to infuse cell therapy that has shown notable effectiveness in treating metastatic melanoma.
The facility features aseptic manufacturing suites, analytical laboratories, dedicated spaces for training and process development, and general office areas.
0